- Home
- TERN vs JELD Comparison
TERN vs JELD Comparison
Compare TERN & JELD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TERN
- JELD
- Stock Information
- Founded
- TERN 2017
- JELD 1960
- Country
- TERN United States
- JELD United States
- Employees
- TERN N/A
- JELD N/A
- Industry
- TERN Biotechnology: Pharmaceutical Preparations
- JELD Forest Products
- Sector
- TERN Health Care
- JELD Basic Materials
- Exchange
- TERN Nasdaq
- JELD Nasdaq
- Market Cap
- TERN 634.5M
- JELD 545.7M
- IPO Year
- TERN 2021
- JELD 2017
- Fundamental
- Price
- TERN $7.30
- JELD $6.25
- Analyst Decision
- TERN Buy
- JELD Hold
- Analyst Count
- TERN 6
- JELD 8
- Target Price
- TERN $13.99
- JELD $6.03
- AVG Volume (30 Days)
- TERN 1.1M
- JELD 1.8M
- Earning Date
- TERN 11-11-2025
- JELD 11-03-2025
- Dividend Yield
- TERN N/A
- JELD N/A
- EPS Growth
- TERN N/A
- JELD N/A
- EPS
- TERN N/A
- JELD N/A
- Revenue
- TERN N/A
- JELD $3,430,185,000.00
- Revenue This Year
- TERN N/A
- JELD N/A
- Revenue Next Year
- TERN N/A
- JELD $2.38
- P/E Ratio
- TERN N/A
- JELD N/A
- Revenue Growth
- TERN N/A
- JELD N/A
- 52 Week Low
- TERN $1.87
- JELD $3.27
- 52 Week High
- TERN $10.70
- JELD $16.43
- Technical
- Relative Strength Index (RSI)
- TERN 52.85
- JELD 54.21
- Support Level
- TERN N/A
- JELD $6.10
- Resistance Level
- TERN $7.67
- JELD $6.66
- Average True Range (ATR)
- TERN 0.41
- JELD 0.31
- MACD
- TERN -0.32
- JELD -0.06
- Stochastic Oscillator
- TERN 93.83
- JELD 30.81
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.
About JELD JELD-WEN Holding Inc.
JELD-WEN Holding Inc is engaged in door and window manufacturing. The company designs, produces, and distributes interior and exterior building products, offering a selection of doors, windows, walls, and related products. The products are used in the new construction of residential single and multi-family homes and non-residential buildings. The firm's operating segments are North America, Europe, and Australasia. It generates a majority of its revenue from North America.